A La Marca — Endo Lab

observational 2021

VP07.01: How adenomyosis changes throughout pregnancy: a retrospective study

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology ·doi:10.1002/uog.24132

To study how adenomyosis modifies in pregnancy and to correlate these changes to maternal and fetal outcomes. Retrospective cohort study including 254 women between 2016 and 2020. Inclusion criteria were: ≧1 transvaginal ultrasound (TV-US) …

nonrandomized-trial 2005

Progestin effects on epidermal growth factor receptor (EGFR) endometrial expression in normal and hyperplastic endometrium

International Journal of Gynecology & Obstetrics ·doi:10.1016/j.ijgo.2005.02.003

The epidermal growth factor (EGF) and its receptor (EGFR) are involved in the control of the human endometrial growth [1]. The EGFR endometrial expression is up-regulated by estrogens [2]. The endometrial EGFR increases during the follicula…

rct 1999

Low-dose danazol after combined surgical and medical therapy reduces the incidence of pelvic pain in women with moderate and severe endometriosis

Human Reproduction ·doi:10.1093/humrep/14.9.2371

The most effective therapy for endometriosis is a matter for debate. The aim of the present randomized study was to evaluate the efficacy of low doses of danazol on recurrence of pelvic pain in patients with moderate or severe endometriosis…

nonrandomized-trial 1999

Short-term treatment of uterine fibromyomas with danazol

Gynecologic and obstetric investigation ·doi:10.1159/000010118

The aim of this study was to evaluate the effects of danazol in reducing the volume of fibromyomas and in the treatment of associated symptoms. Twenty women (34-42 years) with uterine fibromyomas were treated with 400 mg/day of danazol for …